skip to Main Content
September 16, 2020 12:00 - 1:00 PM ET

Market Access Enablement Strategies, Part 1: Launching in a Virtual World

  • This page as PDF


Join Avalere experts for Part 1 of our Market Access Enablement Strategies webinar series to learn about how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.

From value, evidence, and pricing to access, coverage, and reimbursement to insights and commercialization strategy, the COVID-19 pandemic has created new challenges for innovative life sciences companies to bring products to market. Join our experts to learn about the approaches that can be taken in this virtual era to support stakeholder engagement and patient uptake.

Key Topics

  • Pre-/post-launch planning
  • Third-party channel and distribution
  • Patient access strategy
  • Customer models and engagement

Don’t forget to register for Part 2 of our Market Access webinar series.


Sarah Butler , Head, Client Solutions, Marketing & Operations

Sarah Butler specializes in evidence-based medicine, value-based contracting, and strategy development.

Lance Grady , Practice Director, Market Access & Reimbursement

As the leader of the Market Access Practice, Lance Grady devises commercialization strategies focused on value, access, and reimbursement.

Omar Hafez , Managing Director, Market Access & Reimbursement

Omar advises a range of clients on issues including supply chain, drug pricing, launch strategy, and oncology market analytics and planning.

Dana Macher , Managing Director, Market Access & Reimbursement

Dana Macher specializes in market access and commercialization.

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Value-Based Care
Please enter your email address to be notified when new Value-Based Care insights are published.

Back To Top